DLL4 and neoplasm: Since DLL4 and JAG1 have opposing roles in angiogenesis, the identification of upstream signals controlling the expression of one or the other ligand might modulate angiogenesis positively or negatively and have a direct impact on the development of strategies aimed at controlling tumor angiogenesis.